• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性呼吸道乳头状瘤病(RRP)——关于使用人乳头瘤病毒(HPV)疫苗作为辅助治疗的荟萃分析。

Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.

作者信息

Goon Peter, Sauzet Odile, Schuermann Matthias, Oppel Felix, Shao SenYao, Scholtz Lars-Uwe, Sudhoff Holger, Goerner Martin

机构信息

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and Departments of Dermatology & Otolaryngology, National University Health System, Singapore, Singapore.

Bielefeld School of Public Health and Department of Business Administration and Economics, University of Bielefeld, Universitätsstraße 25, 33615, Bielefeld, Germany.

出版信息

NPJ Vaccines. 2023 Apr 1;8(1):49. doi: 10.1038/s41541-023-00644-8.

DOI:10.1038/s41541-023-00644-8
PMID:37005390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10067830/
Abstract

Recurrent Respiratory Papillomatosis(RRP) is a rare disease with severe morbidity. Treatment is surgical. Prevailing viewpoint is that prophylactic HPV vaccines do not have therapeutic benefit due to their modus operandi. Studies on HPV vaccination alongside surgery were meta-analysed to test effect on burden of disease. Databases were accessed Nov and Dec 2021 [PubMed, Cochrane, Embase and Web of Science]. Main outcome measured was: Mean paired differences in the number of surgeries or recurrences per month. Analyses was performed using: Random effect maximal likelihood estimation model using the Stata module Mataan(StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX:StataCorp LLC.) Our results found n = 38 patients, suitable for syntheses with one previous meta-analyses (4 published, 2 unpublished studies) n = 63, total of n = 101 patients. Analyses rendered an overall reduction of 0.123 recurrences or surgeries per month (95% confidence interval [0.064, 0.183]). Our meta-analyses concludes that HPV vaccine is a beneficial adjunct therapy alongside surgery.

摘要

复发性呼吸道乳头状瘤病(RRP)是一种发病率较高的罕见疾病。治疗方法为手术。目前的观点是,预防性HPV疫苗因其作用方式而没有治疗益处。对HPV疫苗与手术联合应用的研究进行了荟萃分析,以测试其对疾病负担的影响。于2021年11月和12月检索了数据库[PubMed、Cochrane、Embase和科学网]。主要测量结果为:每月手术或复发次数的平均配对差异。使用Stata模块Mataan(StataCorp. 2019. Stata统计软件:第16版。德克萨斯州大学站:StataCorp有限责任公司)的随机效应最大似然估计模型进行分析。我们的研究结果发现,有38例患者适合与之前的一项荟萃分析(4项已发表、2项未发表的研究)进行综合分析,共63例,总计101例患者。分析结果显示,每月复发或手术次数总体减少0.123次(95%置信区间[0.064, 0.183])。我们的荟萃分析得出结论,HPV疫苗是手术辅助治疗的有益手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/e3121a79a5f2/41541_2023_644_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/50e89e92761e/41541_2023_644_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/297ef65f4b3a/41541_2023_644_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/e3121a79a5f2/41541_2023_644_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/50e89e92761e/41541_2023_644_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/297ef65f4b3a/41541_2023_644_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d7/10067830/e3121a79a5f2/41541_2023_644_Fig3_HTML.jpg

相似文献

1
Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.复发性呼吸道乳头状瘤病(RRP)——关于使用人乳头瘤病毒(HPV)疫苗作为辅助治疗的荟萃分析。
NPJ Vaccines. 2023 Apr 1;8(1):49. doi: 10.1038/s41541-023-00644-8.
2
The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.人乳头瘤病毒疫苗作为复发性呼吸道乳头瘤病辅助治疗的疗效。
Laryngoscope. 2023 Sep;133(9):2046-2054. doi: 10.1002/lary.30560. Epub 2023 Jan 18.
3
Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis.人乳头瘤病毒疫苗在复发性呼吸道乳头瘤病中的治疗应用:系统评价和荟萃分析。
J Infect Dis. 2019 Mar 15;219(7):1016-1025. doi: 10.1093/infdis/jiy616.
4
Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.HPV 疫苗接种致复发性呼吸道乳头瘤病自发消退:1 例病例研究。
J Voice. 2022 Jul;36(4):587.e21-587.e25. doi: 10.1016/j.jvoice.2020.08.013. Epub 2020 Sep 3.
5
Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.常规人乳头瘤病毒疫苗接种在复发性呼吸道乳头状瘤病管理中的应用
Ann Otol Rhinol Laryngol. 2019 Apr;128(4):309-315. doi: 10.1177/0003489418821695. Epub 2018 Dec 29.
6
Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.人乳头瘤病毒疫苗作为青少年复发性呼吸道乳头瘤病辅助治疗的系统评价
Int J Pediatr Otorhinolaryngol. 2022 Nov;162:111314. doi: 10.1016/j.ijporl.2022.111314. Epub 2022 Sep 13.
7
Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.人乳头瘤病毒疫苗在复发性呼吸道乳头状瘤病中的治疗应用:一例报告
Int J Pediatr Otorhinolaryngol. 2017 Feb;93:103-106. doi: 10.1016/j.ijporl.2016.12.035. Epub 2016 Dec 27.
8
Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.人乳头瘤病毒疫苗接种对复发性呼吸道乳头状瘤病的多年影响。
Laryngoscope. 2020 Feb;130(2):442-447. doi: 10.1002/lary.27993. Epub 2019 Apr 8.
9
Current and future management of recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病的当前及未来管理
Laryngoscope Investig Otolaryngol. 2018 Jan 14;3(1):22-34. doi: 10.1002/lio2.132. eCollection 2018 Feb.
10
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.四价人乳头瘤病毒(6/11/16/18 型)疫苗在复发性呼吸道乳头瘤病患者中的临床疗效。
Eur Arch Otorhinolaryngol. 2014 May;271(5):1135-42. doi: 10.1007/s00405-013-2755-y.

引用本文的文献

1
Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.人乳头瘤病毒介导的复发性呼吸道乳头状瘤病中的局部T细胞失调与免疫检查点表达
Cells. 2025 Jun 27;14(13):985. doi: 10.3390/cells14130985.
2
Therapeutic Impact of Gardasil in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients.加德西(Gardasil)对复发性呼吸道乳头状瘤病的治疗影响:一项关于复发性呼吸道乳头状瘤病患者的回顾性研究
Viruses. 2025 Feb 26;17(3):321. doi: 10.3390/v17030321.
3
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".

本文引用的文献

1
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.复发性呼吸道乳头瘤病患者接种人乳头瘤病毒疫苗的结局:一项非随机临床试验。
JAMA Otolaryngol Head Neck Surg. 2022 Jul 1;148(7):654-661. doi: 10.1001/jamaoto.2022.1190.
2
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.英国英格兰国家 HPV 疫苗接种计划对宫颈癌和 3 级宫颈上皮内瘤变发病率的影响:基于登记的观察性研究。
Lancet. 2021 Dec 4;398(10316):2084-2092. doi: 10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3.
3
复发性呼吸道乳头状瘤病的流行病学、临床、经济和人文负担的系统文献综述
Respir Res. 2024 Dec 18;25(1):430. doi: 10.1186/s12931-024-03057-w.
4
Complete response of laryngeal papillomatosis after HPV vaccination.人乳头瘤病毒疫苗接种后喉乳头状瘤病的完全缓解
Acta Otorhinolaryngol Ital. 2025 Feb;45(1):70-72. doi: 10.14639/0392-100X-N2990. Epub 2024 Oct 18.
5
VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review.血管内皮生长因子作为复发性呼吸道乳头状瘤病的关键因素:一篇叙述性综述
Curr Issues Mol Biol. 2024 Jul 1;46(7):6757-6768. doi: 10.3390/cimb46070403.
6
The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.HPV11 E7 在调节复发性呼吸道乳头状瘤病中 STING 依赖性干扰素 β 反应中的作用。
J Virol. 2024 May 14;98(5):e0192523. doi: 10.1128/jvi.01925-23. Epub 2024 Apr 16.
7
Recent Developments in Human Papillomavirus (HPV) Vaccinology.人乳头瘤病毒(HPV)疫苗学的最新进展。
Viruses. 2023 Jun 26;15(7):1440. doi: 10.3390/v15071440.
8
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?人乳头瘤病毒的流行病学与预防:性别差异依然存在吗?
Vaccines (Basel). 2023 Jun 4;11(6):1060. doi: 10.3390/vaccines11061060.
Emerging concepts in the science of vaccine adjuvants.
疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
4
Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?目前和未来使用已许可的 2 价、4 价和 9 价 VLP HPV 疫苗进行的疫苗临床研究:正在进行什么,需要什么?
Prev Med. 2021 Mar;144:106321. doi: 10.1016/j.ypmed.2020.106321. Epub 2021 Mar 4.
5
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States.人乳头瘤病毒(HPV)疫苗在美国引入后,青少年复发性呼吸道乳头瘤病显著减少。
Clin Infect Dis. 2021 Sep 7;73(5):885-890. doi: 10.1093/cid/ciab171.
6
Identification of 11 Different HPV Subtypes in Adult Patients With Recurrent Respiratory Papillomatosis.在复发性呼吸道乳头瘤病的成年患者中鉴定出 11 种不同的 HPV 亚型。
Otolaryngol Head Neck Surg. 2020 Oct;163(4):785-790. doi: 10.1177/0194599820931817. Epub 2020 Jun 23.
7
Safety of the 9-Valent Human Papillomavirus Vaccine.九价人乳头瘤病毒疫苗的安全性。
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2019-1791. Epub 2019 Nov 18.
8
Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.人乳头瘤病毒疫苗接种对复发性呼吸道乳头状瘤病的多年影响。
Laryngoscope. 2020 Feb;130(2):442-447. doi: 10.1002/lary.27993. Epub 2019 Apr 8.
9
Pattern Recognition Receptors and the Host Cell Death Molecular Machinery.模式识别受体与宿主细胞死亡分子机制
Front Immunol. 2018 Oct 16;9:2379. doi: 10.3389/fimmu.2018.02379. eCollection 2018.
10
Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis.人乳头瘤病毒疫苗在复发性呼吸道乳头瘤病中的治疗应用:系统评价和荟萃分析。
J Infect Dis. 2019 Mar 15;219(7):1016-1025. doi: 10.1093/infdis/jiy616.